OCS Liver PROTECT Continued Access Protocol
Public ClinicalTrials.gov record NCT04186221. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Continued Access Protocol To Evaluate the Effectiveness of the Portable Organ Care System (OCS) Liver for Preserving and Assessing Donor Livers for Transplantation.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Continued Access Protocol to evaluate the effectiveness of the OCS Liver System to preserve and assess donor livers.
Study identification
- NCT ID
- NCT04186221
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 74 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 3, 2020 (Actual)
- Primary completion
- Feb 2, 2021 (Actual)
- Completion
- Feb 2, 2023 (Actual)
- Last update posted
- Jul 24, 2024
2020 – 2023
United States locations
- U.S. sites
- 17
- U.S. states
- 11
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Scripps | La Jolla | California | 92037 | — |
| University of California San Diego | La Jolla | California | 92037 | — |
| UCSF | San Francisco | California | 94143 | — |
| Tampa General | Tampa | Florida | 33606 | — |
| Johns Hopkins | Baltimore | Maryland | 21205 | — |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | — |
| Henry Ford Hospital | Detroit | Michigan | 48202 | — |
| University of Nebraska Medical Center | Omaha | Nebraska | 68198 | — |
| Mount Sinai Hospital | New York | New York | 10029 | — |
| Montefiore Einstein Center for Transplantation | The Bronx | New York | 10467 | — |
| Ohio State University | Columbus | Ohio | 43210 | — |
| Methodist University Hospital | Memphis | Tennessee | 38104 | — |
| University of Texas Southwest | Dallas | Texas | 75390 | — |
| Houston Methodist Hospital | Houston | Texas | 77030 | — |
| The University of Texas Health Science Center at San Antonio | San Antonio | Texas | 78229 | — |
| University of Virginia | Charlottesville | Virginia | 22903 | — |
| Virginia Commonwealth University Health System | Richmond | Virginia | 23298 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04186221, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 24, 2024 · Synced Oct 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04186221 live on ClinicalTrials.gov.